About Indivumed
Indivumed is a company based in Hamburg (Germany) founded in 2002. The company has 178 employees as of December 31, 2021. Indivumed offers products and services including Unique Database, AI Tools, and Cellular Models. Indivumed operates in a competitive market with competitors including GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
- Headquarter Hamburg, Germany
- Employees 178 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Indivumed Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$47.97 M (USD), Debt – Conventional
Jan 09, 2018
-
Investors
European Investment Bank
& 1 more
-
Employee Count
178
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Indivumed
Indivumed offers a comprehensive portfolio of products and services, including Unique Database, AI Tools, and Cellular Models.
Comprehensive database of tumor samples for cancer research and discovery.
Biomathematical tools for target validation in oncology development.
Patient-derived models for validating cancer therapy targets.
People of Indivumed
Unlock access to complete
Software Development Team
5 people
Leadership Team
4 people
Data Analysis and Operations Team
3 people
Finance and Accounting
2 people
Scientist Team
2 people
Operations Team
2 people
Sales and Marketing
2 people
Legal and Compliance
1 people
Unlock access to complete
Funding Insights of Indivumed
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $48.0M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Debt – Conventional - Indivumed | Valuation |
investors |
|
| Nov, 2009 | Amount | Grant - Indivumed | Valuation |
investors |
Investors in Indivumed
Indivumed has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank and National Cancer Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Cancer research is conducted and supported by the institute.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Indivumed
Financial Statements - Indivumed
Indivumed Comparisons
Competitors of Indivumed
Indivumed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| domain | founded_year | HQ Location |
Provider of a biorepository of human clinical specimens
|
|
| domain | founded_year | HQ Location |
Human biological materials for research are supplied via a biorepository.
|
|
| domain | founded_year | HQ Location |
Provider of biobanking services for life sciences industries
|
|
| domain | founded_year | HQ Location |
A blockchain-based platform for tokenizing and incentivizing stem cell donations
|
|
| domain | founded_year | HQ Location |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
Frequently Asked Questions about Indivumed
Indivumed was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Indivumed is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
As of Dec 31, 2021, the latest employee count at Indivumed is 178.
Indivumed was founded in 2002 in Hamburg, Germany, as an integrated oncology company. Biospecimens are collected and preserved rapidly for clinical trials, maintaining molecular patterns akin to those in the human body. Tumor tissue specimens and related molecular analytical services are provided, alongside drug and biomarker development including immunohistochemistry, phosphoprotein profiling, drug profiling, capture microdissection, and genomics services.
Indivumed's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Indivumed offers Unique Database, AI Tools, and Cellular Models.
Indivumed has 2 investors. Key investors include European Investment Bank, and National Cancer Institute.